Humacyte, Inc.HUMANASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +15.43% | +14.35% | +21.48% | +30.43% | +32.58% |
| Weighted Average Shares Diluted Growth | +15.43% | +14.35% | +21.72% | +30.43% | +32.58% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -23.18% | +7.53% | +0.67% | +0.37% | -20.26% |
| Book Value per Share Growth | +0.00% | +0.00% | +13.45% | +0.00% | +0.00% |
| Debt Growth | -69.59% | -71.24% | -14.64% | +368.42% | +72.73% |
| R&D Expense Growth | +23.58% | +2.36% | -27.49% | -7.35% | -24.66% |
| SG&A Expenses Growth | +20.38% | +320.96% | +130.94% | +99.06% | +4.15% |